Table 2 Proportion of patients who received guideline-indicated treatment for which they were eligible according to comorbidity
Guideline-indicated care | Treatments received % (N) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | COPD or asthma | Hypertension | Chronic heart failure | Chronic renal failure | Cerebrovascular disease | Peripheral vascular disease | Number of comorbidities | |||
Pharmacological therapies | 0 | 1 | 2 ≤ | |||||||
 Acute aspirin | 89.8 (66,818) | 90.7 (54,297) | 91.3 (182,918) | 87.2 (14,865) | 87.9 (14,936) | 88.5 (24,549) | 88.2 (13,341) | 86.4 (201,860) | 91.0 (155,972) | 90.1 (91,927) |
 Aspirin at discharge | 86.2 (88,601) | 86.1 (64,560) | 86.8 (225,028) | 81.5 (21,971) | 84.2 (20,580) | 84.0 (35,427) | 84.5 (19,439) | 85.0 (207,794) | 86.4 (178,134) | 85.8 (124,459) |
 P2Y12 inhibitors at discharge | 40.5 (41,639) | 38.6 (29,058) | 39.8 (102,566) | 31.9 (8669) | 42.7 (10,609) | 36.6 (15,726) | 35.6 (8199) | 38.1 (81,619) | 38.3 (77,834) | 39.4 (57,546) |
 β-blockers at discharge | 72.0 (32,712) | 56.7 (13,980) | 74.9 (90,334) | 71.4 (16,417) | 67.6 (6994) | 66.3 (12,766) | 67.2 (7173) | 75.2 (107,956) | 74.2 (73,120) | 69.2 (44,117) |
 ACE inhibitors/ARBs at discharge | 82.6 (81,177) | 78.2 (37,411) | 80.6 (136,249) | 77.5 (19,599) | 72.0 (10,092) | 74.9 (20,538) | 76.9 (12,333) | 74.7 (119,461) | 77.8 (97,090) | 80.7 (90,851) |
 Statins at discharge | 84.8 (89,259) | 83.5 (64,424) | 85.0 (224,238) | 77.0 (21,627) | 80.7 (20,249) | 81.5 (35,656) | 83.0 (19,728) | 82.6 (203,064) | 84.1 (175,625) | 83.8 (124,997) |
Aldosterone antagonists | ||||||||||
 At discharge | 30.1 (520) | 33.4 (117) | 32.6 (519) | 38.1 (408) | N/A | 33.0 (114) | 30.0 (68) | 0.0 (0) | 30.5 (151) | 32.6 |
6 (623) | ||||||||||
 At admission or discharge | 34.5 (597) | 37.7 (132) | 36.9 (587) | 42.3 (453) | N/A | 36.4 (126) | 35.2 (80) | 0.0 (0) | 33.3 (165) | 36.8 |
8 (708) | ||||||||||
Non-invasive therapies | ||||||||||
 Echocardiogram | 56.7 (65,980) | 56.6 (48,031) | 57.5 (165,339) | 54.2 (17,154) | 56.7 (16,429) | 53.5 (26,006) | 57.7 (15,145) | 52.0 (140,591) | 55.7 (126,655) | 57.1 (94,299) |
 ECG | 95.5 (116,764) | 95.7 (85,337) | 96.0 (290,259) | 93.8 (31,722) | 96.1 (29,804) | 95.6 (49,612) | 95.1 (26,268) | 93.9 (263,563) | 95.6 (227,863) | 95.7 (167,033) |
 Cardiac rehabilitation | 73.2 (82,843) | 73.8 (60,629) | 75.6 (212,835) | 62.8 (18,560) | 66.0 (17,914) | 67.5 (31,024) | 72.2 (18,296) | 74.8 (200,239) | 76.0 (169,622) | 72.0 (114,624) |
 Smoking cessation advice | 16.7 (9464) | 19.4 (9819) | 17.4 (24,966) | 8.3 (1248) | 11.8 (1461) | 14.0 (3326) | 16.6 (2693) | 20.2 (32,897) | 18.4 (22,015) | 15.9 (13,102) |
 Dietary advice | 34.8 (40,140) | 32.7 (27,584) | 33.7 (96,587) | 26.2 (8066) | 35.0 (9796) | 30.7 (14,630) | 30.9(8052) | 28.2 (76,044) | 32.1 (72,932) | 33.6 (54,844) |
Invasive therapies | ||||||||||
 Early invasive coronary procedures | 51.2 (59,241) | 48.6 (41,003) | 54.4 (157,090) | 28.7 (8864) | 36.2 (10,158) | 37.9 (18,190) | 46.4 (12,145) | 57.7 (157,354) | 55.5 (126,868) | 46.9 (76,944) |
Cumulative treatment score—median (IQR) | 66.7 (50.0–87.5) | 66.7 (50.0–85.7) | 66.7 (54.5–87.5) | 60.0 (42.9–80.0) | 63.6 (45.5–83.3) | 62.5 (45.5–81.8) | 63.6 (50.0–83.3) | 66.7 (50.0–81.8) | 66.7 (50.0–85.7) | 66.7 (50.0–85.7) |
Percentage of optimal care receipt | 14.3 (14,449) | 14.0 (12,512) | 15.1 (45,657) | 8.6 (2916) | 13.2 (4101) | 12.3 (6377) | 13.2 (3655) | 13.0 (36,413) | 14.5 (34,599) | 14.0 (24,355) |